The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study
Open accessAbstract
OBJECTIVE: To assess risks of mortality associated with use of individual antipsychotic drugs in elderly residents in nursing homes. DESIGN: Population based cohort study with linked data from Medicaid, Medicare, the Minimum Data Set, the National Death Index, and a national assessment of nursing home quality. SETTING: Nursing homes in the United States. PARTICIPANTS: 75,445 new users of antipsychotic drugs (haloperidol, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone). All participants were aged ≥ 65, were eligible for Medicaid, and lived in a nursing home in 2001-5. MAIN OUTCOME MEASURES: Cox proportional hazards models were used to compare 180 day risks of all cause and cause specific mortality by individual drug, with propensity score adjustment to control for potential confounders. RESULTS: Compared with risperidone, users of haloperidol had an increased risk of mortality (hazard ratio 2.07, 95% confidence interval 1.89 to 2.26) and users of quetiapine a decreased risk (0.81, 0.75 to 0.88). The effects were strongest shortly after the start of treatment, remained after adjustment for dose, and were seen for all causes of death examined. No clinically meaningful differences were observed for the other drugs. There was no evidence that the effect measure modification in those with dementia or behavioural disturbances. There was a dose-response relation for all drugs except quetiapine. CONCLUSIONS: Though these findings cannot prove causality, and we cannot rule out the possibility of residual confounding, they provide more evidence of the risk of using these drugs in older patients, reinforcing the concept that they should not be used in the absence of clear need. The data suggest that the risk of mortality with these drugs is generally increased with higher doses and seems to be highest for haloperidol and least for quetiapine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,050
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Schneeweiss, S., Rassen, J. A., Glynn, R. J., Avorn, J., Mogun, H., & Brookhart, M. A. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a663cc · Cited by 1,128
Self-citationRisk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications
Wang, P. S., Schneeweiss, S., Avorn, J., Fischer, M. A., Mogun, H., Solomon, D. H., & Brookhart, M. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052827 · Cited by 959
Self-citationAndreasen, N. C., Pressler, M., Nopoulos, P., Miller, D., & Ho, B.-C. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.040 · Cited by 943
Lehman, A. F., Steinwachs, D. M., & The Co-Investigators of the PORT Project (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033302 · Cited by 910
Schneeweiss, S. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1200 · Cited by 727
Self-citationSchneeweiss, S. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.9.854 · Cited by 711
Self-citationAntipsychotic Drug Use and Mortality in Older Adults with Dementia
Gill, S. S., Bronskill, S. E., Normand, S.-L. T., Anderson, G. M., Sykora, K., Lam, K., Bell, C. M., Lee, P. E., Fischer, H. D., Herrmann, N., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-11-200706050-00006 · Cited by 624
Maher, A. R., Maglione, M., Bagley, S., Suttorp, M., Hu, J.-H., Ewing, B., Wang, Z., Timmer, M., Sultzer, D., & Shekelle, P. G. (2011) · JAMA · doi:10.1001/jama.2011.1360 · Cited by 558
Sturmer, T., Rothman, K. J., Avorn, J., & Glynn, R. J. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq198 · Cited by 446
Self-citationSchneeweiss, S., Setoguchi, S., Brookhart, A., Dormuth, C., & Wang, P. S. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061250 · Cited by 366
Self-citationACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia
Jeste, D. V., Blazer, D., Casey, D., Meeks, T., Salzman, C., Schneider, L., Tariot, P., & Yaffe, K. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301492 · Cited by 365
Rare Outcomes, Common Treatments: Analytic Strategies Using Propensity Scores
Braitman, L. E., & Rosenbaum, P. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-8-200210150-00015 · Cited by 364
Using antipsychotic agents in older patients.
Alexopoulos, G. S., Streim, J. E., Carpenter, D., & Docherty, J. P. (2004) · PubMed · Cited by 327
A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse.
Ray, W. A., Federspiel, C. F., & Schaffner, W. (1980) · American Journal of Public Health · doi:10.2105/ajph.70.5.485 · Cited by 297
A basic study design for expedited safety signal evaluation based on electronic healthcare data
Schneeweiss, S. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1926 · Cited by 255
Self-citationAnticonvulsant Medications and the Risk of Suicide, Attempted Suicide, or Violent Death
Patorno, E. (2010) · JAMA · doi:10.1001/jama.2010.410 · Cited by 245
Psychotic Symptoms in Combat-Related Posttraumatic Stress Disorder
David, D., Kutcher, G. S., Jackson, E. I., & Mellman, T. A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0106 · Cited by 245
Psychoactive medication use in intermediate-care facility residents
Beers, M. H. (1988) · JAMA · doi:10.1001/jama.260.20.3016 · Cited by 229
The Quality of Antipsychotic Drug Prescribing in Nursing Homes
Briesacher, B. A., Limcangco, M. R., Simoni-Wastila, L., Doshi, J. A., Levens, S. R., Shea, D. G., & Stuart, B. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.11.1280 · Cited by 215
Unexplained Variation Across US Nursing Homes in Antipsychotic Prescribing Rates
Chen, Y. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.469 · Cited by 205
Clinical guidelines for establishing remission in patients with depression and anxiety.
Ballenger, J. C. (1999) · PubMed · Cited by 191
Psychoactive Medication Use in Intermediate-Care Facility Residents
Beers, M. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410200072028 · Cited by 190
Variation in Nursing Home Antipsychotic Prescribing Rates
Rochon, P. A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.7.676 · Cited by 183
Snowden, M., Sato, K., & Roy‐Byrne, P. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51417.x · Cited by 171
Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications
Atkins, M., Burgess, A., Bottomley, C., & Riccio, M. (1997) · Psychiatric Bulletin · doi:10.1192/pb.21.4.224 · Cited by 170
Clinical Geriatric Psychopharmacology
(1985) · Journal of Gerontology · doi:10.1093/geronj/40.6.768 · Cited by 160
Huybrechts, K. F., Rothman, K. J., Silliman, R. A., Brookhart, A. M., & Schneeweiß, S. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101406 · Cited by 118
Self-citationLiperoti, R., Onder, G., Landi, F., Lapane, K. L., Mor, V., Bernabei, R., & Gambassi, G. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04597yel · Cited by 102
Setoguchi, S., Wang, P. S., Brookhart, M. A., Canning, C. F., Kaci, L., & Schneeweiß, S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01839.x · Cited by 100
The efficacy, safety, and tolerability of antipsychotics in the elderly.
Maixner, S. M., Mellow, A. M., & Tandon, R. (1999) · PubMed · Cited by 97
Bronskill, S. E., Anderson, G., Sykora, K., Wodchis, W. P., Gill, S. S., Shulman, K. I., & Rochon, P. A. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52212.x · Cited by 96
The Use of Atypical Antipsychotics in Nursing Homes
Liperoti, R., Mor, V., Lapane, K. L., Pedone, C., Gambassi, G., & Bernabei, R. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0918 · Cited by 90
Camp, C. J., Cohen‐Mansfield, J., & Capezuti, E. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.11.1397 · Cited by 76
Rossom, R. C., Rector, T. S., Lederle, F. A., & Dysken, M. W. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02873.x · Cited by 68
Psychoactive medication use in intermediate-care facility residents.
Beers, M. H., Avorn, J., Soumerai, S. B., Everitt, D. E., Sherman, D. S., & Salem, S. (1988) · PubMed · Cited by 66
Self-citationBehavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
LAWLOR, B. A. (2004) · PubMed · Cited by 59
Buckley, P. F. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2012.07.016 · Cited by 52
Psychosocial and Behavioral Interventions for Alzheimer's Disease Patients and Their Families
Beck, C. K. (1998) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199821001-00006 · Cited by 37
Atypical Antipsychotics in Older Adults
Chan, Y., PARISER, S. F., & Neufeld, G. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.10.811.31560 · Cited by 35
Huybrechts, K. F., Brookhart, M. A., Rothman, K. J., Silliman, R. A., Gerhard, T., Crystal, S., & Schneeweiß, S. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr213 · Cited by 26
Self-citationThe older patient: the ongoing challenge of efficacy and tolerability.
Tariot, P. N. (1999) · PubMed · Cited by 21
Value of an Endpoints Committee versus the use of nosologists for validating cause of death
Sesso, H. D., Gaziano, J. M., Glynn, R. J., & Buring, J. E. (2006) · Contemporary Clinical Trials · doi:10.1016/j.cct.2005.11.007 · Cited by 18
Psychotropic medication use for behavioral symptoms of dementia
Wang, P. S., Brookhart, M. A., Setoguchi, S., Patrick, A. R., & Schneeweiß, S. (2006) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-006-0051-6 · Cited by 14
Cited by
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Interventions for preventing delirium in hospitalised non-ICU patients
Siddiqi, N., Harrison, J. K., Clegg, A., Teale, E. A., Young, J., Taylor, J., & Simpkins, S. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005563.pub3 · Cited by 619
Maust, D. T., Kim, H. M., Seyfried, L. S., Chiang, C., Kavanagh, J., Schneider, L. S., & Kales, H. C. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3018 · Cited by 617
Page, V. J., Ely, E. W., Gates, S., Zhao, X. B., Alce, T., Shintani, A., Jackson, J., Perkins, G. D., & McAuley, D. F. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70166-8 · Cited by 410
Ueda, T., Suzukamo, Y., Sato, M., & Izumi, S.-I. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.02.003 · Cited by 330
Metadata
- Authors
- Huybrechts, K. F., Gerhard, T., Crystal, S., Olfson, M., Avorn, J., Levin, R., Lucas, J. A., & Schneeweiss, S.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2012-02-23
- Volume
- 344
- Issue
- feb23 2
- Pages
- e977-e977
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2014699979
- Cited by
- 266
- References
- 46
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.